Latest Headlines

  1. Mopec Group And Lumea Announce Strategic Partnership To Advance Workflow-Driven Innovation In Pathology 5/20/2025

    Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology, today announced a strategic partnership with Lumea, the leader in digital pathology and AI-powered workflow innovation–advancing efficient, precise, and accessible diagnostics across the pathology ecosystem.

  2. Summit Health Announces Internalization Of Genomic Testing Cooperative State-Of-The-Art Next Generation Sequencing DNA And RNA Profiling Tests For Tissue And Liquid Biopsy Of Solid Tumors And Hematologic Neoplasms 5/20/2025

    Summit Health, part of Village MD and Genomic Testing Cooperative (GTC), the global leader in RNA innovation, are excited to announce today the launch of a newly established next generation sequencing service at the Summit Health laboratory in Woodland Park, NJ to offer comprehensive DNA and RNA profiling of solid tumors and hematologic neoplasms.

  3. Bruker Introduces The S8 TIGER Series 3 High-Performance WDXRF Spectrometer For Elemental Analysis In Industry And Research 5/20/2025

    Bruker, a global leader in analytical instrumentation, launches the S8 TIGER Series 3 high-power Wavelength Dispersive X-Ray Fluorescence (WDXRF) spectrometer.

  4. Frame And Labcorp Collaborate To Expand Access To Fertility Care And Testing Services 5/20/2025

    Frame, the collaborative care platform transforming access to reproductive and fertility care, today announced a strategic collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, to enable patients to seamlessly access Labcorp's comprehensive suite of fertility testing services, including hormone and genetic testing.

  5. Bionano Laboratories Announces A Second Category I CPT Code For OGM Established By The AMA; This One For Use In Whole Genome Analysis For Constitutional Genetic Disorders 5/19/2025

    Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announced that the editorial panel of the American Medical Association (AMA) established a new Category I Current Procedural Terminology (CPT®) code for the use of OGM in cytogenomic genome-wide analysis to detect structural and copy number variations related to constitutional genetic disorders.

  6. Revvity's EUROIMMUN Unveils New Fully Automated Instrument For Specialty Testing 5/19/2025

    Revvity, Inc today announced the launch of its new IDS i20 analytical random access platform from EUROIMMUN, enabling full automation of chemiluminescence immunoassays (ChLIA).

  7. Gene Solutions And NEWCL Forge Strategic Partnership To Advance Genetic Testing In Taiwan 5/16/2025

    In a groundbreaking move, Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory with LDTs certification, have joined forces to establish an advanced Next-Generation Sequencing (NGS) laboratory in Taiwan.

  8. Safe, Portable, And Trackable Instrument For Transporting Biological Samples 5/14/2025

    The liquid nitrogen vapor-based CryoPod Carrier from Azenta Life Sciences provides a safe, portable, and trackable solution for hand carrying temperature-sensitive materials between labs, providing protection below -150°C for over 3 hours.

  9. Team Develops Digital Lab For Data- And Robot-Driven Materials Science 5/14/2025

    Researchers at the University of Tokyo and their collaborators have developed a digital laboratory system that fully automates the material synthesis and the structural and physical property evaluation of thin-film samples.

  10. Prevencio Receives FDA Breakthrough Device Designation For HART CADhs, Its Artificial Intelligence-Driven Blood Test For Obstructive Coronary Artery Disease 5/13/2025

    Prevencio, Inc., the leader in artificial intelligence-powered blood tests for cardiovascular diagnostics, announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its HART CADhs test.